Breast Cancer Research

official impact factor 5.79

Open Access Highly Access

Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy

Christos Markopoulos*, Urania Dafni, John Misitzis, Vasilios Zobolas, Evagelos Tzoracoleftherakis, Dimitrios Koukouras, Grigorios Xepapadakis, John Papadiamantis, Basileios Venizelos, Zoh Antonopoulou and Helen Gogas

Breast Cancer Research 2009, 11:R35 doi:10.1186/bcr2320

Accesses  

  • Last 30 days: 76 accesses
  • Last 365 days: 807 accesses
  • All time: 4024 accesses